Open AccessSafety of 50,000-100,000 units of vitamin D3/week in vitamin D-deficient, hypercholesterolemic patients with reversible statin intolerance
Author(s) -
Vybhav Jetty,
Charles J. Glueck,
Ping Wang,
Parth Shah,
Marloe Prince,
Kevin Lee,
Michael Goldenberg,
Ashwin Kumar
Publication year - 2016
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4103/1947-2714.179133
Subject(s) - medicine , vitamin d and neurology , vitamin , gastroenterology , vitamin d deficiency , renal function , calcium , statin , endocrinology
Vitamin D deficiency (<32 ng/mL) is a reversible cause of statin-intolerance, usually requiring vitamin D3 (50,000-100,000 IU/week) to normalize serum D, allowing reinstitution of statins. Longitudinal safety assessment of serum vitamin D, calcium, and estimated glomerular filtration rate (eGFR) is important.